PI3K inhibitors are a class of drugs designed to block the activity of PI3K. These inhibitors aim to ____________ the aberrant signaling caused by PI3K mutations. Some of the first-generation PI3K inhibitors include idelalisib and alpelisib, which have been approved for certain types of ___________ and ____________, respectively.
